Aster DM Healthcare Limited — PPTs, 29-11-2024: Investor Presentation

Aster DM Healthcare Limited is set to merge with Quality Care India Limited (QCIL), a move poised to create one of the top three hospital chains in India, boasting over 10,150 beds across nine states. The merged entity is expected to achieve significant operational synergies, including enhanced revenue potential and a near-term EBITDA upside of 10-15%. Aster's capacity to leverage QCIL's existing network, which encompasses 19 hospitals and additional clinics, labs, and pharmacies, underscores the strategic rationale behind the merger.

The transaction values Aster at an EV/EBITDA multiple of 36.6x for FY24, above QCIL's valuation of 25.2x. Following the merger, Aster promoters and Blackstone will maintain substantial representation on the board, with Dr. Azad Moopen continuing as Executive Chairman. The merger aims to provide an EPS accretive benefit from the first full year of operations, positioning the combined entity for robust growth in the expanding healthcare sector. Investors should view this merger positively, as it enhances market positioning while promising better returns through operational efficiencies. This strategic consolidation minimizes market overlap and builds a strong foundation for future expansion.